Profil
Ronald Law is a professional with a doctorate degree from the University of California, Los Angeles, and undergraduate and graduate degrees from the University of Illinois.
He also has a graduate degree from Whittier Law School.
He is currently a member of the American Heart Association, Inc. In the past, he held senior positions at BioSpecifics Technologies Corp., Takeda Pharmaceutical Co., Ltd., Oramed Pharmaceuticals, Inc., and Takeda Pharmaceuticals International, Inc. He was also an associate professor at the David Geffen School of Medicine.
Dr. Law was a member of the American Diabetes Association.
Aktive Positionen von Ronald Law
| Unternehmen | Position | Beginn |
|---|---|---|
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ronald Law
| Unternehmen | Position | Ende |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Vorstandsvorsitzender | 08.10.2019 |
| ORAMED PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.11.2018 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.10.2016 |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.03.2004 |
Ausbildung von Ronald Law
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services Provides diabetes related medical services | Commercial Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Oramed Pharmaceuticals, Inc.
Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
David Geffen School of Medicine
David Geffen School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Whittier Law School
Whittier Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Development Center Americas, Inc.
Takeda Development Center Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















